Sientra (STU:S0Z0) Research & Development : €11.06 Mil (TTM As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Sientra Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sientra's Research & Development for the three months ended in Sep. 2023 was €2.32 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was €11.06 Mil.

Sientra Research & Development Historical Data

The historical data trend for Sientra's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sientra Research & Development Chart

Sientra Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Research & Development

Get a 7-Day Free Trial

9.62

9.10

7.16

9.25

13.28

Sientra Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Research & Development	Get a 7-Day Free Trial															3.76	4.00	2.53	2.20	2.32

Sientra Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.06 Mil.

Sientra (STU:S0Z0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sientra Research & Development Related Terms

Thank you for viewing the detailed overview of Sientra's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sientra (STU:S0Z0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sientra Inc (STU:S0Z0) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

SIEN:USA S0Z0:Germany

Address

3333 Michelson Drive, Suite 650, Irvine, CA, USA, 92612

Website

https://www.sientra.com

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.

Sientra (STU:S0Z0) Headlines

No Headlines